Fat but fit increases risk of CHD

‘Fat but fit’ people are at increased risk of coronary heart disease (CHD), even if they are otherwise healthy, according to a new study published in the European Heart Journal.

Researchers at Imperial College London and the University of Cambridge, have found that being overweight or obese increases a person’s risk of CHD by up to 28 per cent compared to those with a healthy bodyweight, even if they have healthy blood pressure, blood sugar and cholesterol levels.

The findings add to a growing body of evidence that suggests being ‘fat but fit’ is a myth, and that people should aim to maintain a body weight within a healthy range.

The findings add to a growing body of evidence that suggests being ‘fat but fit’ is a myth, and that people should aim to maintain a body weight within a healthy range.

Storing too much fat in the body is associated with a number of metabolic changes, including increased blood pressure, high blood sugar and altered cholesterol levels, which can lead to disease and poor health.

However, previous studies have revealed a subset of overweight people who appear to lack the adverse health effects of excess weight, leading to them being classified as ‘metabolically healthy obese’ in the medical literature, and ‘fat but fit’ in the media.

In the largest study of its kind to date, scientists used data from more than half a million people in 10 European countries – taken from the European Prospective Investigation into Cancer and Nutrition (EPIC) – to show that excess weight is linked with an increased risk of heart disease, even when people have a healthy metabolic profile.

“Our findings suggest that if a patient is overweight or obese, all efforts should be made to help them get back to a healthy weight, regardless of other factors. Even if their blood pressure, blood sugar and cholesterol appear within the normal range, excess weight is still a risk factor” said lead author Dr Camille Lassale, from Imperial’s School of Public Health and now based at University College London.

After a follow-up period of more than 12 years, a total of 7,637 people in the EPIC cohort experienced CHD events, such as death from heart attack. Researchers then selected a representative group of more than 10,000 individuals as controls, for analysis.

After adjusting for lifestyle factors such as smoking, diet, exercise and socioeconomic status, the researchers found that compared to the healthy normal weight group, those classed as unhealthy had more than double the risk of CHD, whether they were normal weight, overweight or obese.

After adjusting for lifestyle factors such as smoking, diet, exercise and socioeconomic status, the researchers found that compared to the healthy normal weight group, those classed as unhealthy had more than double the risk of CHD, whether they were normal weight, overweight or obese.

Dr Ioanna Tzoulaki, from Imperial’s School of Public Health, said: “I think there is no longer this concept of healthy obese. If anything, our study shows that people with excess weight who might be classed as ‘healthy’ haven’t yet developed an unhealthy metabolic profile. That comes later in the timeline, then they have an event, such as a heart attack.”

According to the researchers, the excess weight itself may not be increasing the risk of heart disease directly, but rather indirectly through mechanisms such as increased blood pressure and high glucose. They add that as no follow up measurements were taken, they cannot show how the group’s health status changed over time. However, they add that what is clear from the study is that population-wide prevention and treatment of obesity is needed in order to ensure public health.

Dr Lassale added: “Overall, our findings challenge the concept of the ‘healthy obese’. The research shows that those overweight individuals who appear to be otherwise healthy are still at increased risk of heart disease.”

The research was funded by the European Union and supported by the UK Medical Research Council (MRC), the British Heart Foundation (BHF) and the National Institute for Health Research (NIHR).

A new class of experimental drugs reduces hot flushes in menopausal women by almost three-quarters in just three days. The treatment, tested by scientists at Imperial College London, also reduces the severity …